Information for patients prescribed an Emerade in Sweden only. For all other countries.
Emerade is an adrenaline auto-injector used for the emergency treatment of severe acute allergic reactions (anaphylaxis) to foods, medicines or insect stings. It can also be used for exercise induced anaphylaxis. If you experience anaphylaxis, use your Emerade immediately.
Emerade is a Prescription only Medicine and is available in Sweden, Norway, Denmark, Finland, France, Spain, the Netherlands, the UK, Ireland and Germany.
Click play to watch the instruction video:
Symptoms can develop rapidly within minutes or over a period of hours after the contact with an allergen.
Symptoms include:
Critical symptoms: You find it hard to breath, your mouth or throat swell, you feel sudden fatigue and dizziness, or experience steady worsening.
If you experience these critical symptoms, inject Emerade immediately. Call 112 and say “anaphylaxis”.
Adrenaline helps raise your blood pressure, stimulates your heart and improves your breathing.
Always have your Emerade with you.
Use Emerade immediately if signs or symptoms of anaphylaxis (life-threatening acute allergic reaction) occur. Do not hesitate to use your Emerade, even if you are not sure if you have anaphylaxis.
Read the instructions carefully and follow your doctor’s advice.
Emerade is for single use. However, if your symptoms don't improve a second injection of Emerade may be administered 5-15 minutes after the first injection.
It is therefore recommended that you consult with your doctor whether you carry more than one Emerade.
The dose will be decided by your doctor depending on your bodyweight.
Store below 25°C. Do not freeze (0°C).
Simple and safe to use: Emerade has only one large needle exit. There is a needle guard following use to protect against needle stick injury.
When flying: You may carry Emerade in your hand luggage. Flight personnel may not know this, therefore you may need your doctor to sign a travel certificate. Print a travel certificate.
Send me free trainer and brochure
It is important that you read the patient information leaflet (pdf).